Colorectal Cancer Trial, Recruiting NCT06082648 Sponsor: Huashan Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06082648
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a tumour very low in the rectum and have had a specific type of surgery (called intersphincteric resection) along with a temporary bowel diversion (called a preventive ileostomy).
  • People who are willing to take part in the study and have signed a consent form agreeing to participate.

Who may not be able to join:

  • People who developed a leakage at the surgical join site or other serious complications after their surgery.
  • People whose cancer is at an advanced stage, has come back, or has spread to other parts of the body.
  • People who have reasons they cannot have an fMRI brain scan, such as having metal implants in their body or a fear of enclosed spaces (confirm with trial site).
  • People who have reasons they cannot receive TMS (a type of brain stimulation treatment), such as metal implants in the skull, a history of epilepsy or seizures, unstable heart conditions, or retinal detachment in the eye (confirm with trial site).
  • People who have a diagnosed brain disease caused by a physical condition, or a history of drug or substance abuse.
  • People who have another diagnosed mental health condition.
  • People who are pregnant or currently breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jianbin Xiang, PhD, Huashan Hospital

Phone: 8621-52889999

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Huashan Hospital
Registry
ClinicalTrials.gov
Start date
1 June 2023
Est. completion
30 October 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The differences of cortical activated areas in task-state fMRI in ISR patients.; The differences of cortical activated areas in task-state fMRI between health volunteers and postoperative ISR patients.; Rectal function scores (Wexner score); Rectal function scores (LARS score); Quality of life Scale (EORTC QLQ-C30); Quality of life Scale (EORTC QLQ-CR38)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov